Chu Grenoble - Hopital Michallon

Grenoble 38043

1 studies enrolling now · 8 studies all time

What they study most

Acute Myocardial Infarction, Atrial Fibrillation, Bleeding, Congestive Heart Failure, Follicular Lymphoma, Gastric Cancer, Gastroesophageal Junction Cancer, Non-Hodgkin Lymphoma, Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Prevention of Stroke or Systemic Embolism, ST-Elevation Myocardial Infarction

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• CHAMPION-AF Clinical Trial — Running, not enrolling
• Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation — Running, not enrolling
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Boston Scientific's Cryoballoon in the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation — Completed
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early
• A Phase 1/2 Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma — Completed
• IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction — Completed